|

Ivonescimab, docetaxel Clinical Trials

1 actively recruiting trial

Also known as: AK112, docetaxel

Pipeline

Phase 3: 1

Top Sponsors

  • Akeso1

Indications

  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Other1 trial

Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.